An interventional study of Gold Nano particle from Pelargonium Graveolens Mouthwash and Chlorhexidine gluconate mouthwash . in Dental Caries, Gingivitis and Periodontitis, sponsored by Ahmed Yousif Mahdi. Status unknown at 1 site in Iraq. Open to male participants aged 7 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-18.
Sponsored by Ahmed Yousif Mahdi · Not applicable, Interventional, and Treatment
The study is randomized controlled trial ... The null hypothesis of the present study is that there is no antibacterial efficacy of gold nanoparticles of pelargonium graveolens mouthwash against Streptococcus mutans and Candida Albicans . Meanwhile the alternative hypothesis of the present study is that gold nanoparticles of pelargonium graveolens mouthwash have antimicrobial activity against Streptococcus mutans and Candida Albicans .
This is double blind study will be conducted among male patients with mild to moderate gingivitis . Those patients aged between (7-14 ) years old who attended the second specialized dental health center in Baquba city/ Diyala governorate/ Iraq. patients will be randomly assigned to one of two study groups the first group is Gold Nano particle from Pelargonium Graveolens Mouthwash , the second Chlorhexidine. by using 15ml of it for one minute two times daily for three weeks. In this study a clinical parameters as ( plaque index, gingival index and calculus index ) were assessed at the base line (before mouthwash use), and then assessed three times at one week interval after the base line assessment through the period of mouthwash use. On the other hand, microbiological aspect were assessed for those patients before and three weeks after the use of Gold Nano particle from Pelargonium Graveolens Mouthwash and Chlorhexidine . After three weeks the mean of plaque, gingival, and culculs indices are significantly reduced after the use of Biogenic Gold Nano particle from Pelargonium Graveolens Leaves Extract Mouthwash.
590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.
This study's planned enrollment of 60 is close to the median of 64 across 478 interventional studies indexed under Gingivitis.
Browse Gingivitis studies →This is the only study on the registry with Ahmed Yousif Mahdi as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Gold Nano particle from Pelargonium Graveolens Mouthwash will be applied as a mouthwash for three weeks and then follow up .
Drug: Gold Nano particle from Pelargonium Graveolens Mouthwash
Chlorhexidine gluconate mouth wash will be applied as a mouthwash for three weeks and then follow up .
Drug: Chlorhexidine gluconate mouthwash .
Gold Nano particle from Pelargonium Graveolens Mouthwash will be applied by using 15ml of it for one minute, two times daily for three weeks and then follow up after three weeks the clinical parameters as ( plaque index, gingival index and calculus index ) and microbiological aspect will be assessed .
Also known as: Gold Nano particle Pelargonium Graveolens
Chlorhexidine gluconate mouthwash will be applied by using 15ml of it for one minute, two times daily for three weeks and then follow up after three weeks the clinical parameters as ( plaque index, gingival index and calculus index ) and microbiological aspect will be assessed .
Also known as: Chlorhexidine gluconate
The incidence of patient with mild to moderate gingivitis using international periodantal disease detection .
The measure will be done using international detection and assessment criteria for diagnosing mild to moderate gingivitis by naked eye and periodantal probe.
Time frame: 3 weeks after mouth wash application
This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.